US Patent Issued to EPICENTRX on Feb. 22 for "Recombinant adenoviruses carrying transgenes" (California Inventors)

  • Christopher Larson

Press/Media

Period23 Feb 2022

Media coverage

1

Media coverage

  • TitleUS Patent Issued to EPICENTRX on Feb. 22 for "Recombinant adenoviruses carrying transgenes" (California Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date23/02/22
    PersonsChristopher Larson
View all 1
View less